Refractory Hypoglycaemia Due to Insulin Autoimmune Syndrome: A Review of Published Cases
DOI:
https://doi.org/10.5281/zenodo.22279408Keywords:
Insulin autoimmune syndrome, Hirata disease, Hypoglycaemia, Insulin autoantibodies, Auoimmune hypoglycaemiaAbstract
Background: Insulin autoimmune syndrome (IAS), or Hirata disease, is a rare cause of spontaneous, often postprandial,
hyperinsulinaemic hypoglycaemia driven by high-titre autoantibodies against endogenous insulin, arising without prior
exogenous insulin exposure. Objective: To review published cases and epidemiological/mechanistic literature on IAS, focusing on drug-induced and idiopathic presentations and management of refractory disease. Methods: Narrative review of individually verified case reports, case series, systematic reviews and diagnostic/management literature. Findings: IAS is disproportionately reported in Japan and linked to HLA-DRB1*0406, but is increasingly recognised worldwide following sulfhydryl-group drugs (methimazole, alpha-lipoic acid) and clopidogrel. Diagnosis rests on markedly elevated total insulin with disproportionate C-peptide, insulin autoantibody positivity, and PEG precipitation to distinguish IAS from insulinoma or factitious hypoglycaemia. Most cases remit after dietary modification and trigger withdrawal within months; refractory disease has responded to corticosteroids, rituximab and immunoadsorption. Conclusions: IAS should be considered early in unexplained hyperinsulinaemic hypoglycaemia to avoid unnecessary insulinoma work-up, reserving immunosuppression for genuinely refractory disease.
References
Hirata, Y., Ishizu, H., Ouchi, N., Motomura, S., Abe, M., Hiraoka, M., et al. (1970) Insulin autoimmunity in a case of spontaneous hypoglycemia. Journal of the Japan Diabetes Society, 13: 312-320.
Lupsa, B.C., Chong, A.Y., Cochran, E.K., Soos, M.A., Semple, R.K., Gorden, P. (2009) Autoimmune forms of hypoglycemia. Medicine (Baltimore), 88(3): 141-153.
Cappellani, D., Macchia, E., Falorni, A., Marchetti, P. (2020) Insulin Autoimmune Syndrome (Hirata Disease): A Comprehensive Review Fifty Years After Its First Description. Diabetes, Metabolic Syndrome and Obesity, 13: 963-978.
Hirata, Y. (1983) Methimazole and insulin autoimmune syndrome with hypoglycemia. Lancet, 2(8357): 1037-1038.
Lin, M., Chen, Y., Ning, J. (2023) Insulin Autoimmune Syndrome: A Systematic Review. International Journal of Endocrinology, 2023: 1225676.
Uchigata, Y., Eguchi, Y., Takayama-Hasumi, S., Omori, Y. (1994) Insulin autoimmune syndrome (Hirata disease): clinical features and epidemiology in Japan. Diabetes Research and Clinical Practice, 22(2-3): 89-94.
Uchigata, Y., Hirata, Y., Omori, Y., Iwamoto, Y., Tokunaga, K. (2000) Worldwide differences in the incidence of insulin autoimmune syndrome (Hirata disease) with respect to the evolution of HLA-DR4 alleles. Human Immunology, 61(2): 154-157.
Yao, D., Jiang, J., Zhou, Q., Feng, C., Chu, J., Chen, Z., Yang, J., Xia, J., Chen, Y. (2024) HLA Alleles Associate with Insulin Autoimmune Syndrome. Diabetes, Metabolic Syndrome and Obesity, 17: 3463.
Uchigata, Y., Hirata, Y., Iwamoto, Y. (2009) Drug-induced insulin autoimmune syndrome. Diabetes Research and Clinical Practice, 83(1): e19-e20.
Ismail, A.A.A. (2016) The insulin autoimmune syndrome (IAS) as a cause of hypoglycaemia: an update on the pathophysiology, biochemical investigations and diagnosis. Clinical Chemistry and Laboratory Medicine, 54(11): 1715-1724.
Lee, S.H., Oh, S.H., Chung, W.Y. (2013) Insulin autoimmune syndrome induced by methimazole in a Korean girl with Graves' disease. Annals of Pediatric Endocrinology & Metabolism, 18(1): 32-35.
Reis, M.Z.R., Fernandes, V.O., Fontenele, E.G.P., Sales, A.P.A.M., Montenegro, R.M., Quidute, A.R.P. (2018) Insulin autoimmune syndrome in an occidental woman: a case report and literature review. Archives of Endocrinology and Metabolism, 62(5): 566-570.
Censi, S., Mian, C., Betterle, C. (2018) Insulin autoimmune syndrome: from diagnosis to clinical management. Annals of Translational Medicine, 6(17): 335.
Bresciani, E., Bussi, A., Bazzigaluppi, E., Balestrieri, G. (2011) Insulin Autoimmune Syndrome Induced by α-Lipoic Acid in a Caucasian Woman: Case Report. Diabetes Care, 34(9): e146.
Baburaj, K., MP, J., Vimal, M.V. (2024) Alpha-lipoic acid induced insulin autoimmune antibody syndrome. Egyptian Journal of Internal Medicine, 36: 64.
Rajpal, A., Kassem, L.S., Moscoso-Cordero, M., Arafah, B.M. (2017) Clopidogrel-Induced Insulin Autoimmune Syndrome: A Newly Recognized Cause of Hypoglycemia in a Patient Without Diabetes. Journal of the Endocrine Society, 1(9): 1217-1223.
Jiang, Y., Wang, L., Shi, F., et al. (2020) Insulin autoimmune syndrome after exposure to clopidogrel: a case report. Endocrine, Metabolic & Immune Disorders Drug Targets, 20(8): 1355-1362.
Calder, G.L., Ward, G.M., Sachithanandan, N., MacIsaac, R.J. (2020) Insulin autoimmune syndrome: a case of clopidogrel-induced autoimmune hypoglycemia. Journal of Clinical Endocrinology and Metabolism, 105(4): dgz301.
Yamada, E., Okada, S., Saito, T., et al. (2016) Insulin autoimmune syndrome during the administration of clopidogrel. Journal of Diabetes, 8(4): 588-589.
Chen, S., Qiang, J., Zhao, B., Tian, R., Yuan, T., Li, M., et al. (2023) Clopidogrel as a Distinctive Cause of Insulin Autoimmune Syndrome: A Systematic Case Review. Diabetes, Metabolic Syndrome and Obesity, 16: 2583-2592.
Chen, F., Yang, J., Liu, Y., Wang, W., Zhu, L., Wang, W., Yang, J., You, W. (2018) Insulin autoimmune syndrome: three case reports. Medicine (Baltimore), 97(51): e13486.
Cryer, P.E., Axelrod, L., Grossman, A.B., Heller, S.R., Montori, V.M., Seaquist, E.R., Service, F.J. (2009) Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism, 94(3): 709-728.
Church, D., Cardoso, L., Bradbury, S., et al. (2017) Diagnosis of insulin autoimmune syndrome using polyethylene glycol precipitation and gel filtration chromatography with ex vivo insulin exchange. Clinical Endocrinology, 86(3): 347-353.
Church, D., Hunter, R.W., Lyall, M., et al. (2017) Resolution of Hypoglycemia and Cardiovascular Dysfunction After Rituximab Treatment of Insulin Autoimmune Syndrome. Diabetes Care, 40(7): e80-e82.
Batra, C.M. (2021) Steroid-Refractory Insulin Autoimmune Syndrome Treated With Rituximab and Continuous Glucose Monitoring. Cureus, 13(7): e16513.
Kroemer, T.M., Erler, A., Tsourdi, E., et al. (2018) Immunoadsorption Followed by Rituximab as a Definitive Treatment for Insulin Autoimmune Syndrome (Hirata Syndrome): A Case Report. Diabetes Care, 41(3): e23-e24.
